...
search icon
gpcr-img

Structure Therapeutics Inc. American Depositary Shares, Common Stock

GPCR

NMQ

$22.2

-$1.66

(-6.96%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.39B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
820.64K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-1.79
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$13.22 L
$62.74 H
$22.2

About Structure Therapeutics Inc. American Depositary Shares, Common Stock

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions. The company also develops ACCG-2671, which is in preclinical trial to treat obesity; ANPA-0073, an oral small molecule agonist targeting the apelin, which is phase 2 ready for selective weight loss or muscle-sparing weight loss; and LTSE-2578, an antagonist that targets lysophosphatidic acid 1 receptor, a G-protein coupled receptors implicated in responses to tissue injury and pro-fibrotic processes, for the treatment of idiopathic pulmonary fibrosis. In addition, it develops programs, including glucose-dependent insulinotropic polypeptide receptor (GIPR) program, which identified multiple GIPR agonist, dual GLP-1R/GIPR agonist, and GIPR antagonist hits for small molecule GIPR modulation that has the potential to provide a treatment in obesity; and GCG program, which identified multiple GCG receptor (GCGR) agonist and dual GLP-1R/GCGR agonist hits for small molecule GCGR modulation. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was incorporated in 2016 and is headquartered in South San Francisco, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameGPCRSectorS&P500
1-Week Return-8.07%0.44%1.41%
1-Month Return-6.01%-4.65%7.29%
3-Month Return-6.53%-11.26%-0.55%
6-Month Return-33.03%-10.35%-1.83%
1-Year Return-40.13%-7.37%11.54%
3-Year Return48%-0.05%43.1%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue20.03K266.35K623.26K949.17K-[{"date":"2020-12-31","value":2.11,"profit":true},{"date":"2021-12-31","value":28.06,"profit":true},{"date":"2022-12-31","value":65.66,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(20.03K)(266.35K)(623.26K)(949.17K)-[{"date":"2020-12-31","value":-2003400,"profit":false},{"date":"2021-12-31","value":-26635300,"profit":false},{"date":"2022-12-31","value":-62325800,"profit":false},{"date":"2023-12-31","value":-94917400,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses15.91K37.70K52.56M102.78M158.23M[{"date":"2020-12-31","value":0.01,"profit":true},{"date":"2021-12-31","value":0.02,"profit":true},{"date":"2022-12-31","value":33.22,"profit":true},{"date":"2023-12-31","value":64.95,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(15.91K)(37.70K)(52.56M)(102.78M)(158.23M)[{"date":"2020-12-31","value":-1590600,"profit":false},{"date":"2021-12-31","value":-3769600,"profit":false},{"date":"2022-12-31","value":-5256100000,"profit":false},{"date":"2023-12-31","value":-10277500000,"profit":false},{"date":"2024-12-31","value":-15822800000,"profit":false}]
Total Non-Operating Income/Expense336.00(122.12K)2.51M26.78M72.02M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-0.17,"profit":false},{"date":"2022-12-31","value":3.49,"profit":true},{"date":"2023-12-31","value":37.18,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(15.74K)(37.82K)(51.30M)(89.38M)(122.22M)[{"date":"2020-12-31","value":-1573800,"profit":false},{"date":"2021-12-31","value":-3781800,"profit":false},{"date":"2022-12-31","value":-5130400000,"profit":false},{"date":"2023-12-31","value":-8938400000,"profit":false},{"date":"2024-12-31","value":-12221600000,"profit":false}]
Income Taxes138.00231.0017.00K236.00K310.00K[{"date":"2020-12-31","value":0.04,"profit":true},{"date":"2021-12-31","value":0.07,"profit":true},{"date":"2022-12-31","value":5.48,"profit":true},{"date":"2023-12-31","value":76.13,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(15.88K)(38.05K)(51.32M)(89.62M)(122.53M)[{"date":"2020-12-31","value":-1587600,"profit":false},{"date":"2021-12-31","value":-3804900,"profit":false},{"date":"2022-12-31","value":-5132100000,"profit":false},{"date":"2023-12-31","value":-8962000000,"profit":false},{"date":"2024-12-31","value":-12252600000,"profit":false}]
Income From Continuous Operations(15.88K)(38.05K)(51.32M)(89.62M)(122.53M)[{"date":"2020-12-31","value":-1587600,"profit":false},{"date":"2021-12-31","value":-3804900,"profit":false},{"date":"2022-12-31","value":-5132100000,"profit":false},{"date":"2023-12-31","value":-8962000000,"profit":false},{"date":"2024-12-31","value":-12252600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(15.88K)(38.05K)(51.32M)(89.62M)(122.53M)[{"date":"2020-12-31","value":-1587600,"profit":false},{"date":"2021-12-31","value":-3804900,"profit":false},{"date":"2022-12-31","value":-5132100000,"profit":false},{"date":"2023-12-31","value":-8962000000,"profit":false},{"date":"2024-12-31","value":-12252600000,"profit":false}]
EPS (Diluted)--(1.14)(2.00)(0.79)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-114,"profit":false},{"date":"2023-12-31","value":-200.16,"profit":false},{"date":"2024-12-31","value":-79,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

GPCR
Cash Ratio 22.94
Current Ratio 23.29

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

GPCR
ROA (LTM) -17.24%
ROE (LTM) -22.85%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

GPCR
Debt Ratio Lower is generally better. Negative is bad. 0.05
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.95

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

GPCR
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.71
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Structure Therapeutics Inc. American Depositary Shares share price today?

Structure Therapeutics Inc. American Depositary Shares (GPCR) share price today is $22.2

Can Indians buy Structure Therapeutics Inc. American Depositary Shares shares?

Yes, Indians can buy shares of Structure Therapeutics Inc. American Depositary Shares (GPCR) on Vested. To buy Structure Therapeutics Inc. American Depositary Shares from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GPCR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Structure Therapeutics Inc. American Depositary Shares be purchased?

Yes, you can purchase fractional shares of Structure Therapeutics Inc. American Depositary Shares (GPCR) via the Vested app. You can start investing in Structure Therapeutics Inc. American Depositary Shares (GPCR) with a minimum investment of $1.

How to invest in Structure Therapeutics Inc. American Depositary Shares shares from India?

You can invest in shares of Structure Therapeutics Inc. American Depositary Shares (GPCR) via Vested in three simple steps:

  • Click on Sign Up or Invest in GPCR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Structure Therapeutics Inc. American Depositary Shares shares
What is Structure Therapeutics Inc. American Depositary Shares 52-week high and low stock price?

The 52-week high price of Structure Therapeutics Inc. American Depositary Shares (GPCR) is $62.74. The 52-week low price of Structure Therapeutics Inc. American Depositary Shares (GPCR) is $13.22.

What is Structure Therapeutics Inc. American Depositary Shares price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Structure Therapeutics Inc. American Depositary Shares (GPCR) is 1.71

What is the Market Cap of Structure Therapeutics Inc. American Depositary Shares?

The market capitalization of Structure Therapeutics Inc. American Depositary Shares (GPCR) is $1.39B

What is Structure Therapeutics Inc. American Depositary Shares’s stock symbol?

The stock symbol (or ticker) of Structure Therapeutics Inc. American Depositary Shares is GPCR

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top